Strategic information disclosure, integrated reporting and the role of intellectual capital
- 14 February 2019
- journal article
- research article
- Published by Emerald Publishing in Journal of Intellectual Capital
- Vol. 20 (1) , 125-143
Abstract
Purpose: The purpose of this paper is to use a theoretical and empirical model to investigate the adoption of the integrated reporting (IR) framework as a strategic choice to signal intellectual capital (IC) to equity investors, with specific reference to the pharmaceutical industry. Design/methodology/approach: The choice of drafting an integrated report is modelled as a means for managers to strategically disclose price-relevant information related to IC. The voluntary disclosure model developed by Verrecchia (1983) is used, also introducing the role of financial analysts to derive a directly reproducible empirical equation. Findings: Theoretically, as IR requires managers to exert an effort in reporting activity, this work shows that in equilibrium, only firms with sufficient IC have decided to adopt IR, resulting in rational investors’ willingness to pay more only for the forecasted earnings of integrated reporters. This theory is tested in the pharmaceutical sector, where the modelling choice is probably more valid, with mixed results. Research limitations/implications: When compliant with the International Integrated Reporting Council’s (IIRC) standards, IR provides the means to disclose IC in a perfectly verifiable way. Furthermore, since the IIRC has only recently been established, the conclusions have only been tested on a limited data set. Originality/value: This work connects the value relevance of IR to IC by adopting an equilibrium approach, which, in turn, provides specific indications of how to build a consistent empirical test of the theory.Keywords
This publication has 55 references indexed in Scilit:
- Strategic Accounting DisclosureFoundations and Trends® in Accounting, 2013
- The impact of intellectual capital disclosure on cost of equity capital: A case of French firmsJournal of Economics, Finance and Administrative Science, 2013
- The value relevance of intellectual capital disclosuresJournal of Intellectual Capital, 2011
- Reflecting on the production of intellectual capital visualisationsAccounting, Auditing & Accountability Journal, 2009
- Intellectual capital and corporate performance in Indian pharmaceutical industryJournal of Intellectual Capital, 2008
- Intellectual capital disclosure and price‐sensitive Australian Stock Exchange announcementsJournal of Intellectual Capital, 2007
- Intellectual capital and capital markets: additional evidenceJournal of Intellectual Capital, 2007
- The relation between intellectual capital and intangible assets of pharmaceutical companiesJournal of Intellectual Capital, 2006
- An empirical investigation of the relationship between intellectual capital and firms’ market value and financial performanceJournal of Intellectual Capital, 2005
- Revalued Financial, Tangible, and Intangible Assets: Associations with Share Prices and Non-Market-Based Value EstimatesJournal of Accounting Research, 1998